These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 16901441

  • 21. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK, Kustra RP, Hammer AE.
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
    [Abstract] [Full Text] [Related]

  • 22. Long-term course of epilepsy in a large cohort of intellectually disabled patients.
    Huber B, Hauser I, Horstmann V, Jokeit G, Liem S, May T, Meinert T, Robertson E, Schorlemmer H, Wagner W, Seidel M.
    Seizure; 2007 Jan; 16(1):35-42. PubMed ID: 17157535
    [Abstract] [Full Text] [Related]

  • 23. Lamotrigine therapy in patients requiring a change in antiepileptic drug regimen.
    Kustra RP, Meador KJ, Evans BK, Leschek-Gelman LM, Groenke DA, Hammer AE, Nanry KP, Messenheimer JA, TARGET Study Group.
    Seizure; 2005 Jun; 14(4):254-61. PubMed ID: 15911360
    [Abstract] [Full Text] [Related]

  • 24. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V, Berkovic SF, Abou-Khalil B, Sperling MR, Johnson ME, Lu S.
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [Abstract] [Full Text] [Related]

  • 25. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.
    Blum D, Meador K, Biton V, Fakhoury T, Shneker B, Chung S, Mills K, Hammer A, Isojärvi J.
    Neurology; 2006 Aug 08; 67(3):400-6. PubMed ID: 16894098
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA, Picard F, de Saint-Martin A, Strumia S, Marescaux C, Hirsch E.
    Epileptic Disord; 1999 Sep 08; 1(3):159-65. PubMed ID: 10937148
    [Abstract] [Full Text] [Related]

  • 27. Lamotrigine in the treatment of epilepsy in people with intellectual disability.
    Besag FM.
    J Intellect Disabil Res; 1998 Dec 08; 42 Suppl 1():50-6. PubMed ID: 10030433
    [Abstract] [Full Text] [Related]

  • 28. Lamotrigine as add-on therapy in treatment-resistant epilepsy. Portuguese Lamotrigine as Add-on Therapy in Treatment-resistant Epilepsy Study Group.
    Pimentel J, Guimarães ML, Lima L, Leitão O, Sampaio MJ.
    J Int Med Res; 1999 Dec 08; 27(3):148-57. PubMed ID: 10505305
    [Abstract] [Full Text] [Related]

  • 29. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N, Besag F, Iivanainen M.
    J Intellect Disabil Res; 1998 Dec 08; 42 Suppl 1():1-15. PubMed ID: 10030426
    [Abstract] [Full Text] [Related]

  • 30. Patterns of lamotrigine use in daily clinical practice during the first 5 years after introduction in the Netherlands.
    Knoester PD, Belitser SV, Deckers CL, Keyser A, Renier WO, Egberts AC, Hekster YA.
    J Clin Pharm Ther; 2004 Apr 08; 29(2):131-8. PubMed ID: 15068401
    [Abstract] [Full Text] [Related]

  • 31. Lamotrigine in absence and primary generalized epilepsies.
    Mikati MA, Holmes GL.
    J Child Neurol; 1997 Nov 08; 12 Suppl 1():S29-37. PubMed ID: 9429128
    [Abstract] [Full Text] [Related]

  • 32. The clinical efficacy of lamotrigine as an antiepileptic drug.
    Pellock JM.
    Neurology; 1994 Nov 08; 44(11 Suppl 8):S29-35. PubMed ID: 7970004
    [Abstract] [Full Text] [Related]

  • 33. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C, Witt JA.
    Epilepsy Behav; 2013 Feb 08; 26(2):182-7. PubMed ID: 23318473
    [Abstract] [Full Text] [Related]

  • 34. Levetiracetam for people with mental retardation and refractory epilepsy.
    Kelly K, Stephen LJ, Brodie MJ.
    Epilepsy Behav; 2004 Dec 08; 5(6):878-83. PubMed ID: 15582836
    [Abstract] [Full Text] [Related]

  • 35. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P, Werhahn KJ, Blaszczyk B, Johnson ME, Lu S.
    Epilepsia; 2014 Jan 08; 55(1):47-56. PubMed ID: 24256083
    [Abstract] [Full Text] [Related]

  • 36. Improvement in quality of life after initiation of lamotrigine therapy in patients with epilepsy in a naturalistic treatment setting.
    Allain H, Schück S, Nachit-Ouinekh F, Plouin P, Brunon AM, Boulliat J, Mercier F, Slama A, Baulac M, El Hasnaoui A.
    Seizure; 2007 Mar 08; 16(2):173-84. PubMed ID: 17208465
    [Abstract] [Full Text] [Related]

  • 37. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.
    Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P.
    N Engl J Med; 1997 Dec 18; 337(25):1807-12. PubMed ID: 9400037
    [Abstract] [Full Text] [Related]

  • 38. Lamotrigine in children with refractory epilepsy.
    Celebi A, Yalnmzoğlu D, Turanli G, Topaloğlu H, Aysun S, Topçu M.
    Turk J Pediatr; 2008 Dec 18; 50(5):426-31. PubMed ID: 19102045
    [Abstract] [Full Text] [Related]

  • 39. Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy.
    Markowitz MA, Mauskopf JA, Halpern MT.
    Neurology; 1998 Oct 18; 51(4):1026-33. PubMed ID: 9781524
    [Abstract] [Full Text] [Related]

  • 40. Topiramate in patients with epilepsy and intellectual disability.
    Martin P, Schreiner A, Rettig K, Schäuble B.
    Epilepsy Behav; 2009 Mar 18; 14(3):496-502. PubMed ID: 19162230
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.